29605J106

(CUSIP Number)
Scott Brannan
11790 Glen Road,
Potomac, MD, 20854
(301) 299-2225

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
06/01/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Based on 62,854,027 shares of the Company's Common Stock outstanding as of June 1, 2026, comprised of (a) 60,881,712 shares of Common Stock outstanding as of April 28, 2026, as reported in the Company's Quarterly Report on Form 10-Q filed with the Commission on May 7, 2026, (b) 1,254,255 shares of common stock issued by the Company in a private placement on June 1, 2026, as reported in the Company's Current Report on Form 8-K filed with the Commission on June 2, 2026 and (c) 718,060 shares of Common Stock currently issuable upon conversion of the Series A Mandatory Convertible Preferred Stock beneficially owned by Reporting Person


SCHEDULE 13D


 
Mitchell P. Rales
 
Signature:/s/ Mitchell P. Rales
Name/Title:Mitchell P. Rales
Date:06/02/2026